Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Aravive (DE:VE11)
BERLIN:VE11
Aravive (VE11) Stock Price & Analysis
0 Followers
VE11 Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€0.03 - €2.22
Previous Close€0.03
Volume0.00
Average Volume (3M)600.00
Market Cap
€2.74M
Enterprise Value-€2.93M
Total Cash (Recent Filing)$8.54M
Total Debt (Recent Filing)$2.43M
Price to Earnings (P/E)N/A
Beta0.85
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding73,562,648
10 Day Avg. Volume0
30 Day Avg. Volume600
Standard Deviation0.26
R-Squared0.06
Alpha0.06
Financial Highlights & Ratios
Price to Book (P/B)5.41
Price to Sales (P/S)240.55
Price to Cash Flow (P/CF)-0.20
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue-0.42
Enterprise Value/Gross Profit-0.32
Enterprise Value/Ebitda0.13
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Aravive News
VE11 FAQ
What was Aravive’s price range in the past 12 months?
Aravive lowest stock price was €0.03 and its highest was €2.22 in the past 12 months.
What is Aravive’s market cap?
Currently, no data Available
When is Aravive’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Aravive’s earnings last quarter?
Currently, no data Available
Is Aravive overvalued?
According to Wall Street analysts Aravive’s price is currently Overvalued.
Does Aravive pay dividends?
Aravive does not currently pay dividends.
What is Aravive’s EPS estimate?
Aravive’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Aravive have?
Currently, no data Available
What happened to Aravive’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Aravive?
Among the largest hedge funds holding Aravive’s share is Baker Bros Advisors LP. It holds Aravive’s shares valued at N/A.
---
Aravive Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Company Description
Aravive
Aravive, Inc. is a clinical-stage biotechnology company, which engages in developing new therapies that target important survival pathways for both advanced solid tumors as well as hematologic malignancies. Its product candidate, Aravive-S6, is a soluble Fc-fusion protein designed to block the activation of the GAS6-AXL signaling pathway by intercepting the binding of GAS6 to its receptor AXL which also promotes metastasis, cancer cell survival, resistance to treatments, and immune suppression. The company was founded on December 10, 2008 and is headquartered in Houston, TX.
---
VE11 Stock 12 Months Forecast
Average Price Target
―Technical Analysis
Best Analysts Covering VE11
1 Year
1 Year Success Rate
0/1 ratings generated profit
1 Year Average Return
-97.80%
reiterated a buy rating a year ago
Copying Thomas Shrader's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -97.80% per trade.
---